Dr. Kathleen T. Brady (USA) M.D., Ph.D.
Distinguished University Professor, Vice President for Research, Medical University of South Carolina
Dr. Brady is an experienced clinical and translational researcher and has been conducting scientific investigations and clinical work in the field of addictions and psychiatric disorders for over 30 years. Her research focuses on pharmacotherapy of substance use disorders, comorbidity of psychiatric disorders and addictions (e.g., posttraumatic stress disorder and bipolar disorder), gender differences and women’s issues in addictions, and the neurobiologic connections between stress and addictions. She has received numerous federal research grants and has published over 300 peer-reviewed journal articles and co-edited 10 books. She is the principal Investigator of MUSC’s Clinical and Translational Science Award (CTSA), Principal Investigator of the Southern Consortium Node of the NIDA-funded Clinical Trials Network and Director of MUSC’s Women’s Research Center. Her dedication to furthering research careers has attracted a number of junior investigators and clinicians. She has mentored over 25 individual NIH-funded faculty development awards (K-awards) and is presently involved in three institutional faculty development programs (CTSA KL2; BIRCWH, NIDA K-12). She has been the Co-Director of MUSC’s NIH- funded post-doctoral fellowship program focused on translational research training in addictions for 15 years.
Dr. Alex Baldacchino (UK) MD, MRCPsych, FRCPsych, FRCPE, FISAM, MPhil, PhD
My main professional interest lies in improving the lives of individuals with a history of substance misuse problems. I hold a joint clinical academic position with the University of St Andrews as Professor of Medicine, Psychiatry and Addictions together with NHS Scotland as Senior Consultant and Clinical Director in Addiction Medicine with NHS Fife.
My research portfolios have a common thread of understanding the comorbid conditions (physical and psychological) arising as a result of chronic abuse of pharmacological agents of dependence potential especially opioids and alcohol. I am interested in utilising informatics and other digital health science systems, clinical outcome data, neuropsychological and neuroimaging processes amongst many other possibilities in order to identify and minimise risks present in this patient population
I graduated as a doctor in Malta in 1987 gaining my MD in the process. I eventually decided to study psychiatry as my clinical specialisation following a period of internal medicine jobs. I therefore joined the basic and higher psychiatric schemes in the UK (Cambridge, Edinburgh, Fife and London) in order to fulfil my requirements as a general psychiatrist and as a specialist in addiction medicine. I was awarded my Membership and Fellowship with the Royal College of Psychiatrists (United Kingdom) (MRCPsych in 1994 and FRCPsych in 2007) and Fellowship with the Royal College of Physicians (Edinburgh) (FRCPE) in 2016. Always interested in research and teaching in addiction medicine I pursued an academic career alongside my basic medical and higher psychiatric training. I joined as a lecturer and senior lecturer with St George’s Hospital Medical School in London and then with Ninewells Hospital Medical School in Dundee. I was awarded my MPhil in Psychiatry from the University of Edinburgh in 1996 and a PhD in Medicine from the University of Dundee in 2012.
I am an Executive Board Member and Co-Chair for the Training and Education Committee of the International Society of Addiction Medicine (ISAM). In 2016 I have been awarded the ISAM Fellowship (FISAM). I am also founding member for the European Network for Training, Education and Research (ENTER)-Mental Health and the Centre for Addiction Research and Educations Scotland (CARES). Other positions include Associate Director for the Social Dimensions of Health Institute (SDHI), NHS Fife Research and Development (R&D) Director and President for ISAMDundee2015 World Congress.
Last but certainly not least I am honoured to spend time with patients who need the best of clinical care and compassion and where, I hope, my intervention makes a difference in their quality of life.
Dr. Riaz Khan (Switzerland)
Dr. Gregory Bunt (USA) M.D.
Dr. Gregory Bunt graduated medical school in 1983 from NYU School of Medicine, and completed his residency in Psychiatry at the Albert Einstein College of Medicine in 1987.
He was among the first to complete the Fellowship in Addiction Psychiatry at NYU School of Medicine (1989), and has since been on the NYU Medical School Faculty in the Division of Alcoholism and Drug Abuse, currently as an Assistant Clinical Professor of Psychiatry. He is a diplomat of the American Board of Psychiatry and Neurology with Special Added Qualifications in Addiction Psychiatry.
Dr. Bunt is the Immediate Past President of the New York Society of Addiction Medicine and currently the President of the International Society of Addiction Medicine. He has been the Medical Director for Daytop Village and Daytop International for 25 years. He has authored over a dozen publications, and speaks nationally and internationally about addiction medicine and therapeutic communities.
H.E. Dr Hamad Al Ghafri MBBS, MPH, PhD
H.E. Dr Hamad Al Ghafri is the Director General and the Head of the WHO Collaborative Centre for substance use prevention and treatment of substance use disorders (National Rehabilitation Centre Abu Dhabi). He received his medical degree from the Faculty of Medicine, Jordan University of Science and Technology in 1999 and his Masters in Public Health from Tulane School of Public Health and Tropical Medicine, Tulane University, USA in 2002. He obtained his PhD from the Faculty of Medicine, University of Aberdeen, United Kingdom in 2013.
Dr Hamad Al Ghafri serves in many national and international bodies. He is the Head of Higher Committee for Treatment, Rehabilitation and Social Re-integration and a Board Member of Anti Dugs Council in the UAE. He is also a member of the Advisory Board of the College of Medicine and Health Sciences of the United Arab Emirates University.
Internationally he is the Chair of the Commissioners of the International Centre for Credentialing and Education of Addiction Professionals (ICCE) of the Colombo Plan. He is also the Vice President of the Arab Federation for Drug Prevention since 2005. He was a member of the Management Board that established the new journal the International Journal of Prevention and Treatment of Drug Use Disorders (IJPTSUD). Under his leadership this will be re-launched as the International Addiction Review (IAR) in 2017. He is a Mental Health Advisor to the Eastern Mediterranean Regional Office (EMRO) of the WHO and Chair of the Technical Advisory Group (TAG) of UNODC and WHO. He is a Board member of the International Society for Addiction Medicine and was the chair of the local organizing committee of ISAM 2017 conference. He is also Emeritus Professor at the Faculty of Medicine, Jordan University of Science and Technology, Jordan.
His research interests include public health aspects and prevention of addiction, particularly in Arab countries. He has published widely in these areas. He has a particular interest in promoting research in the developing world and dissemination of research information.
In recognition of his contribution to his field and the country, Dr. Hamad Al Ghafri was awarded the Sheik Rashed Award for Science and Culture in 2003 and 2014. In 2017, he was awarded the honor of Lifetime Membership of the American Society for Addiction Medicine.
I have extensive experience and expertise in studying the neurobiology of addictions. Over the past 20 years, I have investigated addictive behaviors and disorders from translational and interdisciplinary perspectives. I have investigated how a neurobiological understanding of addictive processes may be used to advance treatments for drug addictions. I was amongst the first to describe adolescence as a neurodevelopmental period of addiction vulnerability and have published extensively on adolescent risk behaviors including substance misuse. I have studied motivational and emotional processing in addictions. I have served as PI on multiple NIH (NIDA, NIAAA) R01 grants (continuous support for more than a decade) and have been PI on multiple center grants. I have established ongoing research collaborations in multiple countries including China, South Korea, Hungary, Spain, Italy and elsewhere. My international research includes multiple methodologies including brain imaging, genetics, clinical trials and epidemiological surveys. I consult on a regular basis to the World Health Organization on matters of addiction and am thus familiar with cultural and jurisdictional considerations in studying and understanding addictions. I have mentored over 100 individuals in the area of addiction research. I am currently a PI on a NIDA K12 grant that supports training of junior faculty to develop into the next generation of clinical researchers developing new and more effective treatments for people with addictions. I have also recently been designated a High Level Foreign Talent for collaborative work in China. I am currently a mentor to five individuals with K01 support.
Dr. Henrietta M Bowden-Jones (UK) FRCPsych, BA (Hons), DOccMed, MD (Imperial)
Dr Henrietta Bowden-Jones is the Founder and Director of the National Problem Gambling Clinic in the UK, the only NHS service ( CNWL NHS Trust) designated for the treatment of pathological gamblers now in its tenth year.
She runs a gambling disorders research group and has been the recipient of Medical Research Council grants and a Wolfson Fellowship as well as several prizes and awards.
She is a medical doctor specialised in Addiction psychiatry and an Honorary Clinical Senior Lecturer, Dept of Medicine, Imperial College where she teaches and where she obtained her Medical Doctorate on the topic of “Ventromedial Prefrontal Cortex impairment as a predictor of early relapse in Alcohol Dependency”
Current roles include:
President Elect of the Medical Women’s Federation
Royal College of Psychiatrists’ Spokesperson on Behavioural Addictions Board Member of the International Society of Addiction Medicine.
Member Royal Society of Medicine’s Psychiatry Council.
She has published extensively on behavioural addictions in research journals, has edited three textbooks and regularly lectures at national and international level on the neuroscience and clinical aspects of behavioural addictions. Her website which includes all publications is www.henriettabowdenjones.com
Dr. Nady el-Guebaly MD, FRCPC, DPH, DPsych, DABAM, CISAM, DFASAM, DFAAAP, EFACP, DFCPA
Dr. el-Guebaly’s introduction to mental health and addiction medicine dates back to 1969 during initial psychiatric training in the United Kingdom, followed by training in Canada and the United States
Addiction related work includes being the current Professor and Head of Division of Addiction, Department of Psychiatry at the University of Calgary, and the founding past Medical Director of the Calgary Health Region Addiction Centre and Program. Dr. el-Guebaly was the Founding Past President of the International Society of Addiction Medicine, its Executive Medical Director for another 6 years, and currently Chief Examiner of the International Certification Examination and Senior Editor of the recent Textbook of Addiction Treatment: International Perspectives (Springer 2015).
Dr. el-Guebaly completed three 3-year terms as Board Chair of the Alberta Gaming Research Institute, and is now the Alberta Gambling Research Institute’s current Research Director as well as Editor in Chief of the Canadian Journal of Addiction for the last 4 years. These interests have resulted in 260 peer-reviewed papers, 80 chapters, 568 presentations, and 60 past and current grants totaling $7 million.
He is a member, of Alberta’s Responsible Gambling Advisory Committee, the Royal College Addiction Medicine Specialty Committee, the Provincial Addiction Curricula and Experiential Skills Training for Alberta Health Services, and the CSAM Conference committee.
Helena Hansen, MD, Ph.D., is Associate Professor in the Departments of Anthropology and Psychiatry at NYU. She has published widely in clinical and social science journals ranging from JAMA and NEJM to Social Science and Medicine and Medical Anthropology, on faith healing of addiction in Puerto Rico, psychiatric disability under welfare reform, opioids and race, ethnic marketing of pharmaceuticals, and structural competency. Her first book, Addicted to Christ: Remaking Men in Puerto Rican Pentecostal Drug Ministries was published by University of California Press in 2018, and her second book, Structural Competency in Medicine and Mental Health: A Case-Based Approach to Treating the Social Determinants of Health, with co-editor Jonathan Metzl, was published by Springer Press in 2019. She has received major funding from NIDA, the Mellon Foundation, and the Robert Wood Johnson Foundation.
Mrs. Marilyn Dorozio
Marilyn specializes in event management and organization. From the initial proposal to project conclusion, clients worldwide know that their event will be managed with the same project management process Marilyn uses in every conference she takes on.
Sometimes referred to as the “organizing guru extraordinaire” Marilyn can also wrestle a client’s office from chaos to clarity by creating administrative systems for their paperwork and data, especially the financial, which typically is the stopping point for many small business owners.
Fluent in English, Spanish and a working knowledge of French, Marilyn is well-versed in differing cultural expectations and settings and offers the same C-Suite experience to each and every client.
Past Board Members no Longer on Board:
|Wayne Moran||Hong Kong|
|Joao da Silva||Brazil|
|Maria Cristina Delgado Pich||Argentina|
|Tarek Gawad, Past President||Egypt|